Fig. 5From: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancerROC curve analysis of the CCL20-IL-17A-based diagnostic model in distinguishing CRC cases with early stage from controls in the validation dataset. ROC curves of the model for CRC cases with early stage (a), low (b) and high (c) CEA level groupBack to article page